US Stock MarketDetailed Quotes

RANI Rani Therapeutics

Watchlist

6.152
+0.042+0.69%

Trading May 14 11:30 ET

161.82MMarket Cap-4768P/E (TTM)

Rani Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

22.64%-9.4M

-10.15%-51.24M

14.70%-12.48M

-17.26%-14.3M

-19.10%-12.3M

-29.85%-12.15M

-44.25%-46.52M

-27.78%-14.63M

-9.69%-12.2M

-83.51%-10.33M

Net income from continuing operations

12.20%-14.78M

-7.17%-67.88M

18.95%-14.06M

-13.10%-18.33M

-16.90%-18.66M

-21.72%-16.83M

-19.32%-63.34M

-30.34%-17.34M

43.53%-16.21M

-191.08%-15.97M

Depreciation and amortization

31.91%248K

50.00%822K

30.46%227K

54.61%218K

54.92%189K

69.37%188K

10.26%548K

53.98%174K

17.50%141K

-4.69%122K

Other non cash items

37.11%436K

51.37%1.27M

8.50%319K

38.26%318K

98.75%318K

102.55%318K

671.56%841K

29,300.00%294K

1,537.50%230K

180.70%160K

Change In working capital

155.04%1.16M

-520.43%-2.14M

-85.37%-2.99M

-56.24%-864K

-8.84%1.26M

-64.79%456K

114.84%509K

-13.43%-1.61M

72.42%-553K

302.94%1.38M

-Change in prepaid assets

57.91%499K

-44.16%282K

-44.05%348K

36.01%-926K

-10.67%544K

-56.17%316K

125.57%505K

29.58%622K

41.11%-1.45M

2,536.00%609K

-Change in payables and accrued expense

161.15%1.04M

-247.79%-1.14M

-41.62%-2.83M

-70.95%321K

4.83%976K

-45.42%399K

-39.19%768K

-5.10%-2M

144.47%1.11M

-28.71%931K

-Change in other current assets

----

---245K

----

--0

----

-Change in other current liabilities

-45.95%-378K

-36.39%-1.04M

-11.02%-262K

-22.75%-259K

-63.75%-262K

-64.97%-259K

---764K

---236K

---211K

---160K

Cash from discontinued investing activities

Operating cash flow

22.64%-9.4M

-10.15%-51.24M

14.70%-12.48M

-17.26%-14.3M

-19.10%-12.3M

-29.85%-12.15M

-44.25%-46.52M

-27.78%-14.63M

-9.69%-12.2M

-83.51%-10.33M

Investing cash flow

Cash flow from continuing investing activities

149.67%10.29M

141.22%29.86M

3,004.60%13.27M

116.36%11.67M

308.18%789K

1,723.23%4.12M

-14,215.42%-72.44M

-68.63%-457K

-71.35M

-178.68%-379K

Net PPE purchase and sale

92.74%-18K

24.09%-1.23M

68.49%-167K

-5.04%-479K

11.61%-335K

2.36%-248K

-219.96%-1.62M

-95.57%-530K

---456K

-178.68%-379K

Net investment purchase and sale

135.92%10.31M

143.90%31.09M

18,312.33%13.44M

117.14%12.15M

--1.12M

--4.37M

---70.82M

--73K

---70.89M

--0

Cash from discontinued investing activities

Investing cash flow

149.67%10.29M

141.22%29.86M

3,004.60%13.27M

116.36%11.67M

308.18%789K

1,723.23%4.12M

-14,215.42%-72.44M

-68.63%-457K

---71.35M

-178.68%-379K

Financing cash flow

Cash flow from continuing financing activities

1,412.50%121K

-99.20%233K

-99.35%96K

-99.65%49K

63.27%80K

-62.40%29.01M

2,709.47%14.87M

-80.32%14.08M

103.09%49K

Net issuance payments of debt

----

--0

----

1,138.41%29.57M

--14.9M

----

Proceeds from stock option exercised by employees

-8.33%121K

24.61%395K

-21.95%96K

-46.21%78K

81.63%89K

--132K

1,119.23%317K

--123K

1,015.38%145K

--49K

Net other financing activities

----

81.72%-162K

--0

---29K

---9K

---124K

---886K

---152K

----

Cash from discontinued financing activities

Financing cash flow

1,412.50%121K

-99.20%233K

-99.35%96K

-99.65%49K

63.27%80K

--8K

-62.40%29.01M

2,709.47%14.87M

-80.32%14.08M

103.09%49K

Net cash flow

Beginning cash position

-76.86%6.36M

-76.58%27.51M

-80.26%5.47M

-91.71%8.05M

-81.93%19.48M

-76.58%27.51M

60.77%117.45M

-78.64%27.72M

40.20%97.18M

40.67%107.84M

Current changes in cash

112.63%1.01M

76.49%-21.14M

520.75%892K

96.29%-2.58M

-7.26%-11.43M

16.55%-8.02M

-302.60%-89.95M

98.28%-212K

-214.95%-69.46M

-45.05%-10.66M

End cash Position

-62.14%7.38M

-76.86%6.36M

-80.26%5.47M

-91.71%8.05M

-81.93%19.48M

-76.58%27.51M

-78.64%27.72M

40.20%97.18M

Free cash flow

24.04%-9.42M

-9.00%-52.47M

16.58%-12.65M

-16.82%-14.78M

-18.02%-12.64M

-29.00%-12.4M

-46.97%-48.13M

-29.34%-15.16M

-13.79%-12.65M

-85.76%-10.71M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	22.64%-9.4M	-10.15%-51.24M	14.70%-12.48M	-17.26%-14.3M	-19.10%-12.3M	-29.85%-12.15M	-44.25%-46.52M	-27.78%-14.63M	-9.69%-12.2M	-83.51%-10.33M
Net income from continuing operations	12.20%-14.78M	-7.17%-67.88M	18.95%-14.06M	-13.10%-18.33M	-16.90%-18.66M	-21.72%-16.83M	-19.32%-63.34M	-30.34%-17.34M	43.53%-16.21M	-191.08%-15.97M
Depreciation and amortization	31.91%248K	50.00%822K	30.46%227K	54.61%218K	54.92%189K	69.37%188K	10.26%548K	53.98%174K	17.50%141K	-4.69%122K
Other non cash items	37.11%436K	51.37%1.27M	8.50%319K	38.26%318K	98.75%318K	102.55%318K	671.56%841K	29,300.00%294K	1,537.50%230K	180.70%160K
Change In working capital	155.04%1.16M	-520.43%-2.14M	-85.37%-2.99M	-56.24%-864K	-8.84%1.26M	-64.79%456K	114.84%509K	-13.43%-1.61M	72.42%-553K	302.94%1.38M
-Change in prepaid assets	57.91%499K	-44.16%282K	-44.05%348K	36.01%-926K	-10.67%544K	-56.17%316K	125.57%505K	29.58%622K	41.11%-1.45M	2,536.00%609K
-Change in payables and accrued expense	161.15%1.04M	-247.79%-1.14M	-41.62%-2.83M	-70.95%321K	4.83%976K	-45.42%399K	-39.19%768K	-5.10%-2M	144.47%1.11M	-28.71%931K
-Change in other current assets	----	---245K	----	----	----	----	--0	----	----	----
-Change in other current liabilities	-45.95%-378K	-36.39%-1.04M	-11.02%-262K	-22.75%-259K	-63.75%-262K	-64.97%-259K	---764K	---236K	---211K	---160K
Cash from discontinued investing activities
Operating cash flow	22.64%-9.4M	-10.15%-51.24M	14.70%-12.48M	-17.26%-14.3M	-19.10%-12.3M	-29.85%-12.15M	-44.25%-46.52M	-27.78%-14.63M	-9.69%-12.2M	-83.51%-10.33M
Investing cash flow
Cash flow from continuing investing activities	149.67%10.29M	141.22%29.86M	3,004.60%13.27M	116.36%11.67M	308.18%789K	1,723.23%4.12M	-14,215.42%-72.44M	-68.63%-457K	-71.35M	-178.68%-379K
Net PPE purchase and sale	92.74%-18K	24.09%-1.23M	68.49%-167K	-5.04%-479K	11.61%-335K	2.36%-248K	-219.96%-1.62M	-95.57%-530K	---456K	-178.68%-379K
Net investment purchase and sale	135.92%10.31M	143.90%31.09M	18,312.33%13.44M	117.14%12.15M	--1.12M	--4.37M	---70.82M	--73K	---70.89M	--0
Cash from discontinued investing activities
Investing cash flow	149.67%10.29M	141.22%29.86M	3,004.60%13.27M	116.36%11.67M	308.18%789K	1,723.23%4.12M	-14,215.42%-72.44M	-68.63%-457K	---71.35M	-178.68%-379K
Financing cash flow
Cash flow from continuing financing activities	1,412.50%121K	-99.20%233K	-99.35%96K	-99.65%49K	63.27%80K	8K	-62.40%29.01M	2,709.47%14.87M	-80.32%14.08M	103.09%49K
Net issuance payments of debt	----	--0	--0	----	----	----	1,138.41%29.57M	--14.9M	----	----
Proceeds from stock option exercised by employees	-8.33%121K	24.61%395K	-21.95%96K	-46.21%78K	81.63%89K	--132K	1,119.23%317K	--123K	1,015.38%145K	--49K
Net other financing activities	----	81.72%-162K	--0	---29K	---9K	---124K	---886K	---152K	----	----
Cash from discontinued financing activities
Financing cash flow	1,412.50%121K	-99.20%233K	-99.35%96K	-99.65%49K	63.27%80K	--8K	-62.40%29.01M	2,709.47%14.87M	-80.32%14.08M	103.09%49K
Net cash flow
Beginning cash position	-76.86%6.36M	-76.58%27.51M	-80.26%5.47M	-91.71%8.05M	-81.93%19.48M	-76.58%27.51M	60.77%117.45M	-78.64%27.72M	40.20%97.18M	40.67%107.84M
Current changes in cash	112.63%1.01M	76.49%-21.14M	520.75%892K	96.29%-2.58M	-7.26%-11.43M	16.55%-8.02M	-302.60%-89.95M	98.28%-212K	-214.95%-69.46M	-45.05%-10.66M
End cash Position	-62.14%7.38M	-76.86%6.36M	-76.86%6.36M	-80.26%5.47M	-91.71%8.05M	-81.93%19.48M	-76.58%27.51M	-76.58%27.51M	-78.64%27.72M	40.20%97.18M
Free cash flow	24.04%-9.42M	-9.00%-52.47M	16.58%-12.65M	-16.82%-14.78M	-18.02%-12.64M	-29.00%-12.4M	-46.97%-48.13M	-29.34%-15.16M	-13.79%-12.65M	-85.76%-10.71M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall